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Relation of cyclic guanosine monophosphate and 
cyclic adenosine monophosphate in reducing the 
toxic effects of protamine administration 
To the Editor: 
We read with great interest he article by Raikar and 
associates 1 regarding nitric oxide inhibition to relieve the 
adverse effects of protamine on blood pressure. They 
declared that hypotension caused by protamine adminis- 
tration can be blocked by nitrous oxide inhibition. We 
would like to add our experience to their information. 
Adverse effects of protamine administration on various 
organ systems have been known for a long time. These 
changes were attributed to the increased complement levels 
associated with an increase in thromboxane and leukotriene 
levels. These mediators may impair the function of organs 
such as the heart and lungs, although these changes are 
mostly clinically insignificant. We 2 documented that leuko- 
triene and thromboxane l vels increased after heparin rever- 
sal with protamine. These changes, which were associated 
with an increase in cyclic guanosine monophosphate 
(cGMP) levels and a reduction in cyclic adenosine mono- 
phosphate (cAMP) levels, adversely affected myocardial 
function. Monitoring cardiac output with a fast-response 
thermistor allowed us to calculate the ejection fraction 
changes in the right ventricle. After protamine administra- 
tion, while right ventricular end-diastolic volume became 
stable, right ventricular end-systolic volume increased signif- 
icantly, indicating the same degree of impairment in myo- 
cardial contractility. However, we did not observe any signif- 
icant change in pulmonary artery pressure. These pressure 
changes were associated with a temporary defect in myocar- 
dial oxidative metabolism, as indicated by the changes in 
myocardial oxygen consumption and myocardial lactate x- 
traction. Prostacyclin usage reduced the toxic mediator e- 
lease and improved myocardial function. After protamin e 
administration, we observed that protamine use decreased 
the cGMP level in the blood and increased the cAMP level 
in the blood. 2' 3 In light of this study, we hypothesized that a 
fall in cAMP level and a rise in cGMP level are responsible 
for the toxic manifestations of heparin reversal with prota- 
mine, similar to our observation during ischemic reperfu- 
sion. 4 On the basis of this information, we used aminophyl- 
line, a phosphodiesterase inhibitor, to increase the cAMP 
level and observed that aminophylline use reduced the toxic 
mediator elease and preserved myocardial function. 5 Fi- 
nally, adverse ffects of protamine on myocardial function 
can be controlled with agents that increase the cAMP levei. 
S. Fehmi Katircio~lu, MD 
O~uz Ta~demir, MD 
Kemal Bayazit, MD 
Department of Cardiovascular Surgery 
Turkiye Yiitksek htisas Hastanesi 
Ankara, Turkey 
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Reply to the Editor: 
We appreciate the comments of Dr. Katircio~,lu and his 
colleagues. As noted in their letter, the adverse ffects of 
protamine may be mediated through a variety of mecha- 
nisms, including the complement system. In our study, we 
measured the serum level of cyclic guanosine monophos- 
phate (cGMP) and found no significant change with the 
administration of pr0tamine. Therefore we could not con- 
clude that a fall in the cGMP level correlated with the 
adverse ffects of protamine. This investigation focused on 
inhibition of the nitric oxide pathway, which decreased the 
systemic hypotension produced by protamine administra- 
tion. 
Attempts to attenuate the adverse ffects of protamine 
have met with variable degrees of success. There may be 
several effectors of the systemic effects of protamine, and 
these mechanisms might be expected to cause different 
clinical manifestations during protamine reversal of heparin. 
Goya V. Raikar, MD 
HartzeIl V. Schaff, MD 
Section of Cardiovascular Surgery 
Mayo Clinic 
200 First St. SW 
Rochester, MN 55905 
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Is left ventricular outflow tract obstruction really 
relieved on long-term follow-up? 
To the Editor." 
Luciani and associates I report good results in their 
article titled "One-Stage Repair of Interrupted Aortic 
Arch, Ventricular Septal Defect, and Subaortic Obstruc- 
tion in the Neonate: A Novel Approach." However, I am 
unsure about the long-term results. 
I treated a baby girl, not a neonate, who had a simple 
ventricular septal defect (VSD) associated with infundib- 
ular posterior malalignment, which caused only a 30 mm 
Hg pressure gradient through the left ventricular outflow 
tract (LVOT). Preoperative chocardiographic examina- 
tion showed that she had a large perimembranous VSD 
with a mild pressure gradient between the left ventricle 
and ascending aorta, which resulted from posterior eal- 
alignment of the infundibular septum to the LVOT. 
Cardiac catheterization showed that the right ventricular/ 
left ventricular pressure ratio was 0.9 and the pressure 
gradient through the LVOT was only 30 mm Hg. Cardiac 
angiography also showed that the infundibular septum 
significantly deviated to the LVOT and the ascending 
aorta was relatively small (6 mm). 
The patient was treated with catecholamines for cardiac 
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failure caused by pulmonary hypertension, but her respira- 
tory distress progressed. Because of her low weight (2850 
gin) and mild pressure gradient through the LVOT (30 mm 
Hg), we merelY closed the VSD through the right atrium 
after inducing cardiac arrest with a crystalloid cardioplegic 
solution when she was 2 months of age. On closure of the 
VSD, a Dacron patch was attached with interrupted 5-0 
polypropylene sutures. Stay sutures placed on the infundib- 
ular side of the VSD were inserted from the left side of the 
conal septum to the upper margin of the VSD. Moreover, we 
used as small a patch as possible for closure of the VSD to 
prevent protrusion of the patch into the LVOT and to pull 
the conal septum toward the right ventricular side. 
The baby's postoperative course was uneventful. No 
pressure gradient in the LVOT was found, and the 
protrusion of the infundibular septum into the LVOT was 
completely repaired, as revealed by the echocardiographic 
examination before her discharge. However, follow-up 
echocardi0graphy showed that the subaortic stenosis; 
which caused a pressure gradient of 30 mm Hg, had 
recurred 1 year after the operation. This gradient gradu- 
ally increased because of the development of subaortic 
stenosis associated with hypertrophy of the conal septum 
at the left ventricular side. Three years after the opera- 
tion, cardiac atheterization was performed and the pres- 
sure gradient was found to be 80 mm Hg. Consequently, I 
think that the hypertrophic subaortic muscle will need to 
be resected in the near future. 
With Bore and colleagues, 2 1 now believe that when the 
infundibular septum malaligns with the LVOT, resulting 
in subaortic stenosis, the septum should be resected, with 
care taken to avoid injuring the aortic valve at the initial 
operation. This should be done even if the cardiac anom- 
aly is complex and the pressure gradient is mild. 
Kouichi Hisatomi, MD 
Second Department of Surgery 
Faculty of Medicine 
Kagoshima University 
8-35-1 8akuragaoka 
Kagoshima City, Japan 
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Reply to the Editol:" 
I read Dr. Hisatomi's case report with interest. Dr. Hi- 
satomi's patient had a ventricular septal defect (VSD) and 
subaortic stenosis as a result of the realignment of the 
infundibular septum. Although er anatomy issimilar to that 
of the neonates we reported on with interrupted aortic arch 
and subaortic stenosis, she clearly belongs to a different 
subset of patients. Dr. Hisatomi describes the successful 
repair of the VSD with the attachment of the VSD sutures 
along the left side of the superior margin of the infundibular 
septum. By downsizing the patch and anchoring the superior 
margin of the patch to the left of the septum, Dr. Hisatomi 
successfully closed the VSD and relieved the left ventricular 
outflow tract obstruction that existed before the operation. 
In follow-up, he noted the recurrence of the subaortic 
gradient to a level of 80 mm Hg. He now concludes that he 
will need to reoperate to relieve the subaortic obstruction 
and theorizes that he should have performed this procedure 
at the first operation. 
I agree with Dr. Hisatomi's conclusion that another 
operation is needed to relieve the subaortic obstruction. 
However, I disagree with his deduction based on one case 
that his previous operation was unsuccessful. In review of 
the literature, the recurrence rate of subaortic obstruction 
after different forms of repair, including resection of the 
infundibular membrane, has varied from 17% to 67% 
(peak gradient > 25 mm Hg). 1-4 In our report, there was 
no early or midterm (14 months) recurrence in a group of 
neonates with subaortic areas with Z values greater than 4 
deviations below the normal values. I believe this case 
report is of interest, but it would not persuade me to 
change my technique. Further, VSD closure without re- 
section of the infundibulum, placing the sutures on the left 
superior margin of the VSD and downsizing the patch, has 
permitted excellent survival (100%) in our current series 
with good midterm relief of suba0rtic stenosis. A risk 
factor for the recurrence of aortic and subaortic obstruc- 
tion may be the size of the aortic valve anulus and whether 
or not it is bicuspid. We have noted recurrence of 
obstruction in three infants referred to our center who 
have had aortic annular dimensions less than 5 mm and a 
bicuspid valve at the initial operation. We are following 
this group of infants with interest. 
In conclusion, these infants represent a difficult subset 
of patients. We need to define a more consistent way of 
repairing the VSD with acceptable morbidity and mortal- 
ity that can be reproduced by many different centers. I 
believe the operation advocated in our article can be 
reproduced by many centers with good results. 
Vaughn A. Starnes, MD 
Children's Hospital of Los Angeles 
Division of Cardiothoracic Surgery 
USC School of Medicine 
1510 San Pablo St., Suite 415 
Los Angeles, CA 90033-4612 
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